Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
External Beam Radiotherapy for Unresectable Hepatocellular Carcinoma. A Multicenter Phase I/II Trial.
Sponsor: Swiss Cancer Institute
This PHASE1/PHASE2 trial investigates Liver Cancer and is currently completed. Swiss Cancer Institute leads this study, which shows 8 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Aug 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
▶ Show 3 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jun 2019 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Swiss Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .